Moderna COVID-19 Vaccine Candidate
On November 30, 2020, Moderna, Inc., a biotechnology company that specializes in RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines…
On November 30, 2020, Moderna, Inc., a biotechnology company that specializes in RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines…
According to the CDC (Centers for Disease Control and Prevention) measles cases worldwide increased to 869 770 in 2019, the highest number reported since 1996…
On November 20, Pfizer Inc. and BioNTech SE announced they will submit a request to the U.S. Food and Drug Administration (FDA) for Emergency Use…
Recently the U.S. Food and Drug Administration (FDA) announced about a new multi-year study to enhance food safety. The launch of this study follows a…
On November 12, was announced that the FDA (Food and Drug Administration of the U.S.) and CDC (Centers for Disease Control and Prevention), in collaboration…
The Food and Drug Administration of the U.S. (FDA) recently authorized monoclonal antibody for treatment of COVID-19. On November 9 FDA okayed an emergency use…
On November 3, CVS Health and Alzheimer’s Association announced about team up to fight Alzheimer disease for second consecutive year. This is the second November…
This October, the National Institutes of Health (NIH) began an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator…
In an open letter, October 16, Pfizer chairman and CEO Albert Bourla, announced that BioNTech COVID-19 vaccine will be ready for FDA submission by late…
On August 23 the Food and Drug Administration (FDA)approved an Emergency Use Authorization (EUA)* for COVID-19 convalescent plasma for patients with COVID-19 treatment. But in…